Clinical features of Pseudomonas cepacia pneumonia in an epidemic among immunocompromised patients

Chest

Volumn 103, Issue 6, 1993, Pages 1706-1709

  Yamagishi, Y ^a   Fujita, J ^a   Takigawa, K ^a   Negayama, K ^a   Nakazawa, T ^a   Takahara, J ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B; C REACTIVE PROTEIN; CARUMONAM; CEFOTIAM; CEFTAZIDIME; CEFUZONAM; IMIPENEM; LATAMOXEF; MINOCYCLINE; OFLOXACIN; PIPERACILLIN; POLYMYXIN B; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL PNEUMONIA; BACTERIUM CONTAMINATION; BURKHOLDERIA CEPACIA; CLINICAL ARTICLE; EPIDEMIC; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INHALATIONAL DRUG ADMINISTRATION; LEUKOCYTE COUNT; LUNG CAVITY; LUNG INFILTRATE; NEBULIZER; PLEURA EFFUSION; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 0027273443     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.103.6.1706     Document Type: Article

References (27)

1. LA Carson MS Favero WW Bond NJ Petersen Morphological, biochemical, and growth characteristics of Pseudomonas cepacia from distilled water Appl Microbiol 25 1973 476 483
2. RE Dixon RA Kaslow DC Mackel CC Fulkerson GF Mallison Aqueous quaternary ammonium antiseptics and disinfectants: use and misuse JAMA 236 1976 2415 2417
3. OC Tablan National surveillance of P cepacia study group, Cystic Fibrosis Foundation: national surveillance of Pseudomonas cepacia colonization of cystic fibrosis patients-an update [abstract] Pediatr Pulmonol 1989 138 (suppl 4)
4. A Isles I Maclusky M Corey R Cold C Prober P Fleming Pseudomonas cepacia infection in cystic fibrosis: an emerging problem J Pediatr 104 1984 206 210
5. MJ Thomassen CA Demko JD Klinger RC Stern Pseudomonas cepacia colonization among patients with cystic fibrosis: a new opportunist Am Rev Respir Dis 131 1985 791 796
6. OC Tablan WJ Martone CF Doershuk RC Stern MJ Thomassen JD Klinger Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis: risk factors and outcomes Chest 91 1987 527 532
7. OC Tablan TL Chorba DV Schidlow JW White KA Hardy PH Gilligan Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome J Pediatr 107 1985 382 387
8. R Gold E Jin H Levison A Isles PC Fleming Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia J Antimicrob Chemother 12A 1983 331 336
9. MJ Thomassen CA Demko CF Doershuk RC Stern JD Klinger Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis Am Rev Respir Dis 134 1986 669 671
10. KA Hardy KL McGowan MC Fisher DV Schidlow Pseudomonas cepacia in the hospital setting: lack of transmission between cystic fibrosis patients J Pediatr 109 1986 51 54
11. JJ LiPuma JE Mortensen SE Dasen TD Edlind DV Schidlow JL Burns Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers J Pediatr 113 1988 859 862
12. JR Tillotson AM Lerner Pneumonias caused by gram negative bacilli Medicine 45 1966 65 76
13. JR Tillotson AM Lerner Characteristics of nonbacteremic Pseudomonas pneumonia Ann Intern Med 68 1968 295 307
14. MT Esselmann PV Liu Lecithinase production by gram-negative bacteria J Bacteriol 81 1961 939 945
15. G Sierra A simple method for the detection of lipolytic activity of microorganisms and some observations on the influence of the contact between cells and fatty substrates Antonie van Leeuwenhoek 23 1957 15 22
16. PA Sokol DE Ohman BH Iglewski A more sensitive plate assay for detection of protease production by Pseudomonas aeruginosa J Clin Microbiol 9 1979 538 540
17. ML Vasil DP Krieg JS Kuhns JW Ogle VD Shortridge RM Ostroff Molecular analysis of hemolytic and phospholipase C activities of Pseudomonas cepacia Infect Immun 58 1990 4020 4029
18. JA Reinarz AK Pierce BB Mays JP Sanford The potential role of inhalation therapy equipment in nosocomial pulmonary infections J Clin Invest 44 1965 831 839
19. AK Pierce EB Edmondson G McGee J Ketchersid RG Loudon JP Sanford An analysis of factors predisposing to gram-negative bacillary necrotizing pneumonia Am Rev Respir Dis 94 1966 309 315
20. JD Sobel N Hashman G Reinherz D Merzbach Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination Am J Med 73 1982 183 186
21. LJ Pallent DJ Hugo DJW Grant A Davies Pseudomonas cepacia as contaminant and infective agent J Hosp Infect 4 1983 9 13
22. C Randall The problem of Pseudomonas cepacia in a hospital Can J Public Health 71 1980 119 123
23. BJ Rosenstein DE Hall Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis Johns Hopkins Med J 147 1980 188 189
24. RH Poe HR Marcus GL Emerson Lung abscess due to Pseudomonas cepacia Ann Rev Respir Dis 115 1977 861 865
25. RH Dailey EJ Benner Necrotizing pneumonitis due to the pseudomonad “eugonic oxidizer-group 1.” N Engl J Med 279 1968 361 362
26. GB Stover DR Drake TC Montie Virulence of different pseudomonas species in a burned mouse model: tissue colonization by Pseudomonas cepacia Infect Immun 41 1983 1099 1100
27. A Prince Antibiotic resistance of Pseudomonas species J Pediatr 108 1986 830 834